Related Experiment Video
Updated: Jan 17, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.0K
Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management
Madeeha Shahzadi1, Renee Monderer, Michael J Thorpy
1Neurology Department, Albert Einstein College of Medicine, NY, USA.
Current Opinion in Pulmonary Medicine
|September 24, 2025
Summary
Idiopathic hypersomnia, a sleep disorder causing excessive daytime sleepiness, is increasingly understood. New treatments like low-sodium oxybate offer hope for managing this condition, distinct from narcolepsy.
Area of Science:
- Sleep Medicine
- Neurology
Background:
- Idiopathic hypersomnia is a chronic sleep disorder causing excessive daytime sleepiness.
- It is often underrecognized and misdiagnosed, distinct from narcolepsy.
- Limited treatment options historically existed for this condition.
Purpose of the Study:
- To review evolving approaches to understanding and managing idiopathic hypersomnia.
- To highlight recent advances in diagnosis and treatment.
- To address the challenges of underrecognition and misdiagnosis.
Main Methods:
- Literature review of recent advances in idiopathic hypersomnia.
- Analysis of diagnostic criteria and clinical features.
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- Idiopathic hypersomnia is clinically distinct from narcolepsy.
- Low-sodium oxybate (LXB) is the first FDA-approved medication specifically for idiopathic hypersomnia.
- Off-label treatments include modafinil, pitolisant, and stimulants, with ongoing research into novel agents like orexin-2 receptor agonists.
Conclusions:
- Improved understanding of pathophysiology and clinical features enhances diagnosis and treatment.
- Therapeutic innovations offer hope for better symptom control and quality of life.
- Continued research is vital for refining strategies and understanding idiopathic hypersomnia.
Keywords:
clarithromycinflumazenilidiopathic hypersomnianarcolepsyorexinorexin agonistsoxybateserdexmethylphenidatetherapytreatmentMore Related Videos
Related Concept Videos
01:19Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
01:07Narcolepsy
500
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
500
01:27Insomnia
410
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
410
01:24Sleep-Wake Cycles
2.7K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.7K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
518
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
518
01:23Sedatives and Hypnotics: Overview
1.4K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.4K